The New York Sun

Join
National

Drug That Is Already in Use Could Slow Down Aging in Humans

The medication notably improved skin aging signs and enhanced both immune and cardiovascular functions.

Via pexels.com
Overall increases in life expectancy are slowing down in countries with the longest-living populations, a study finds. Via pexels.com
JOSEPH CURL
JOSEPH CURL

Researchers and scientists are exploring the potential of a drug traditionally used to prevent organ rejection in kidney transplant patients, rapamycin, as an agent to slow the aging process.

Have an account? Log In

To continue reading, please select:

Limited Access

Enter your email to read for FREE

Get 1 FREE article

Continue with
or
Unlimited Access

Join the Sun for a PENNY A DAY

$0.01/day for 60 days

Cancel anytime

100% ad free experience

Unlimited article and commenting access

Full annual dues ($120) billed after 60 days

View all membership options
By continuing you agree to our
Privacy Policy and Terms of Service.
JOSEPH CURL
JOSEPH CURL

Mr. Curl covered the White House for a dozen years as a correspondent for the Washington Times. He also ran the Drudge Report for four years as the morning editor.

Advertisement
The New York Sun

Sections

NationalForeignPoliticsArts+EconomyEducationJusticeOpinionWatchCrossword

More

MembershipBecome a FounderAdvertiseEventsNewslettersShopSubmissionsContactLegalAbout

© 2025 The New York Sun Company, LLC. All rights reserved.

Use of this site constitutes acceptance of our Terms of Use and Privacy Policy. The material on this site is protected by copyright law and may not be reproduced, distributed, transmitted, cached or otherwise used.

The New York Sun

Sign in or  Create a free account

or
By continuing you agree to our Privacy Policy and Terms of Use